Skip to main content
Clinical Trials/IRCT20141007019432N5
IRCT20141007019432N5
Not Yet Recruiting
Phase 3

Study of the effectiveness of Cord Blood Platelet Gel (CBPG) for treatment of Epidermolysis Bullosa (EB) ulcers

Vice Presidency for Science and Technology0 sites15 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Vice Presidency for Science and Technology
Enrollment
15
Status
Not Yet Recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice Presidency for Science and Technology

Eligibility Criteria

Inclusion Criteria

  • The wound of EB should be on the hand
  • The patients that have EB
  • Both of genders can be entered this study.
  • The surface of wound should be more than 10 cm2 and less than 20 cm2

Exclusion Criteria

  • The patients that they have some diseases such as diabetes ,allergy and coagulation of blood .
  • The wound of EB that has a very low or high expansion .

Outcomes

Primary Outcomes

Not specified

Similar Trials